Top-Tier Medical Device Manufacturer Renews Agreement with OmniComm

A leading cardiovascular medical device manufacturer has renewed its contract with OmniComm Systems Inc., a global provider of eClinical solutions, for another 5 years. The agreement extends and expands the previous five-year agreement which generated over $2.5 Million in revenue for the company over the past three years. The company expects revenue for this customer to increase.

"We are grateful for the opportunity to continue an important long-standing relationship," said Stephen Johnson, COO of OmniComm Systems. "We have been able to demonstrate to this client, through a collaborative approach, the benefits over time of operational efficiencies gained through use of our products and services. As a result, we expect the customer to expand its relationship with OmniComm."

The manufacturer, who focuses on providing innovative therapeutic solutions for complex medical problems, is currently running numerous studies involving several different product lines, and plans to deploy these studies using OmniComm's Software as a Service (SaaS) offering.

About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large-scale institutions to efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.